Literature DB >> 12669958

Computation of log BB values for compounds transported through carrier-mediated mechanisms using in vitro permeability data from brain microvessel endothelial cell (BMEC) monolayers.

Helen H Usansky1, Patrick J Sinko.   

Abstract

PURPOSE: To explore the possibility of determining in vivo log BB values (the logarithm value of brain to plasma concentration ratio) from in vitro permeability data measured in brain microvessel endothelial cell (BMEC) monolayers.
METHODS: An equilibrium mathematical model was developed: log BB = log(Ca/Cb) + log Kbr:pl, where Cb and Ca are the drug concentrations at equilibrium in the basolateral (B) and apical (A) sides of BMECs in an A-to-B directional diffusion system and Kbr:pl is the brain-plasma partition coefficient. With this model, murine log BB values were calculated for 24 pharmaceutical compounds, mostly Pgp substrates.
RESULTS: Calculated log BB values correlated well to experimental values (r2 = 0.854, slope = 0.907 +/- 0.080), demonstrating that the model could reasonably predict brain penetration for compounds that are involved in carrier-mediated transport mechanisms. For a second data set that included volatile organic compounds (log BB = log Kbr:pl), log Kbr:pl values were also shown to correlate well with their respective experimental log BB values (r2 = 0.876, slope = 0.973 +/- 0.082), demonstrating that log Kbr:pl is an excellent descriptor for log BB when a compound penetrates the blood-brain barrier by passive diffusion only.
CONCLUSION: The equilibrium model demonstrated a reasonable ability to compute in vivo log BB values, regardless of the involvement or mechanisms of carrier-mediated transport.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12669958     DOI: 10.1023/a:1022647903205

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  40 in total

1.  In vitro model for evaluating drug transport across the blood-brain barrier.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1999-04-05       Impact factor: 15.470

2.  Prediction of the brain-blood distribution of a large set of drugs from structurally derived descriptors using partial least-squares (PLS) modeling.

Authors:  J M Luco
Journal:  J Chem Inf Comput Sci       Date:  1999 Mar-Apr

Review 3.  Evaluation of the BBMEC model for screening the CNS permeability of drugs.

Authors:  K W Otis; M L Avery; S M Broward-Partin; D K Hansen; H W Behlow; D O Scott; T N Thompson
Journal:  J Pharmacol Toxicol Methods       Date:  2001 Jan-Feb       Impact factor: 1.950

4.  Contribution of P-glycoprotein to bunitrolol efflux across blood-brain barrier.

Authors:  J Matsuzaki; C Yamamoto; T Miyama; H Takanaga; H Matsuo; H Ishizuka; Y Kawahara; M Kuwano; M Naito; T Tsuruo; Y Sawada
Journal:  Biopharm Drug Dispos       Date:  1999-03       Impact factor: 1.627

5.  Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers.

Authors:  E V Batrakova; S Li; D W Miller; A V Kabanov
Journal:  Pharm Res       Date:  1999-09       Impact factor: 4.200

6.  New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy.

Authors:  C Rousselle; P Clair; J M Lefauconnier; M Kaczorek; J M Scherrmann; J Temsamani
Journal:  Mol Pharmacol       Date:  2000-04       Impact factor: 4.436

7.  In vitro blood-brain barrier permeability of nevirapine compared to other HIV antiretroviral agents.

Authors:  S L Glynn; M Yazdanian
Journal:  J Pharm Sci       Date:  1998-03       Impact factor: 3.534

8.  In vitro and in vivo transport of zidovudine (AZT) across the blood-brain barrier and the effect of transport inhibitors.

Authors:  R Masereeuw; U Jaehde; M W Langemeijer; A G de Boer; D D Breimer
Journal:  Pharm Res       Date:  1994-02       Impact factor: 4.200

9.  Disposition of all-trans- and 13-cis-retinoic acids and n-hydroxyethylretinamide in mice after intravenous administration.

Authors:  C C Wang; S Campbell; R L Furner; D L Hill
Journal:  Drug Metab Dispos       Date:  1980 Jan-Feb       Impact factor: 3.922

10.  The application of bovine brain microvessel endothelial-cell monolayers grown onto polycarbonate membranes in vitro to estimate the potential permeability of solutes through the blood-brain barrier.

Authors:  M V Shah; K L Audus; R T Borchardt
Journal:  Pharm Res       Date:  1989-07       Impact factor: 4.200

View more
  3 in total

1.  Prediction of passive blood-brain partitioning: straightforward and effective classification models based on in silico derived physicochemical descriptors.

Authors:  Santiago Vilar; Mayukh Chakrabarti; Stefano Costanzi
Journal:  J Mol Graph Model       Date:  2010-04-03       Impact factor: 2.518

2.  Physicochemical selectivity of the BBB microenvironment governing passive diffusion--matching with a porcine brain lipid extract artificial membrane permeability model.

Authors:  Oksana Tsinman; Konstantin Tsinman; Na Sun; Alex Avdeef
Journal:  Pharm Res       Date:  2010-10-14       Impact factor: 4.200

3.  New Myrtenal-Adamantane Conjugates Alleviate Alzheimer's-Type Dementia in Rat Model.

Authors:  Stela Dragomanova; Maria Lazarova; Aldar Munkuev; Evgeniy Suslov; Konstantin Volcho; Nariman Salakhutdinov; Amina Bibi; Jóhannes Reynisson; Elina Tzvetanova; Albena Alexandrova; Almira Georgieva; Diamara Uzunova; Miroslava Stefanova; Reni Kalfin; Lyubka Tancheva
Journal:  Molecules       Date:  2022-08-25       Impact factor: 4.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.